Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
51.9M
-
Number of holders
-
61
-
Total 13F shares, excl. options
-
30.6M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$170M
-
Value change
-
+$10.4M
-
Put/Call ratio
-
0
-
Number of buys
-
27
-
Number of sells
-
-19
-
Price
-
$5.57
Significant Holders of ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) as of Q4 2024
73 filings reported holding ABEO - ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value as of Q4 2024.
ABEONA THERAPEUTICS INC. - Common Stock, $0.01 par value (ABEO) has 61 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 30.6M shares
of 51.9M outstanding shares and own 58.98% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (3.9M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.69M shares), Nantahala Capital Management, LLC (3.53M shares), MILLENNIUM MANAGEMENT LLC (2.12M shares), Western Standard LLC (2.08M shares), VANGUARD GROUP INC (1.97M shares), Vivo Capital, LLC (1.84M shares), Rosalind Advisors, Inc. (1.81M shares), Laurion Capital Management LP (1.31M shares), and 683 Capital Management, LLC (792K shares).
This table shows the top 61 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.